Back to search
FDAFDA · Food and drugs·Recall number D-231-2013

NOOTROPA COGNITIVE ENHANCEMENT SUPPLEMENT, 400 mg Aniracetam Capsules 60 count bottle, OTC Manufactured & Packaged in the USA for NOOTROPA.COM. DEVELOPED BY: Digital Superfuture Limited Arntel Building 9B 148 Des Voeux Rd. Hong Kong.

Published April 10, 2013 · Recall initiated: March 11, 2013

Summary

FDA records drug Class II recall D-231-2013, published April 10, 2013 and initiated March 11, 2013. Recalling firm: Palmer Natural Products; Status: Terminated; Reported quantity: 672 bottles; Lot: Lot HJLA,. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Marketed Without an Approved NDA/ANDA: The products are unapproved drugs

What to do

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Palmer Natural Products
Distributor
Florida, Idaho, California and Hong Kong. This product can be ordered on line.
Lot
Lot HJLA,
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was NOOTROPA COGNITIVE ENHANCEMENT SUPPLEMENT, 400 mg Aniracetam Capsules 60 count bottle, OTC Manufactured & Packaged in the USA for NOOTROPA.COM. DEVELOPED BY: Digital Superfuture Limited Arntel Building 9B 148 Des Voeux Rd. Hong Kong. recalled?

Yes. FDA published recall D-231-2013 on April 10, 2013. Reported hazard: Marketed Without an Approved NDA/ANDA: The products are unapproved drugs

What should I do if I have this product?

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit